Scientists track rare nerve disease to pave way for future treatments
NCT ID NCT05008874
Summary
This study aimed to better understand how disabilities from Adrenomyeloneuropathy (AMN) change over time in adults. Researchers observed 65 adult men with AMN to track their walking ability and quality of life. The goal was to gather information to help design future treatment trials, as there are currently no approved treatments for this progressive nerve disorder.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amsterdam UMC
Amsterdam, Netherlands
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Stanford Neuroscience Health Center
Stanford, California, 94304, United States
-
University of Leipzig Medical Center
Leipzig, Germany
-
University of Utah
Salt Lake City, Utah, 84112, United States
-
Weill Medical College of Cornell University
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.